Clinical Trial Update: A Study to Evaluate Transplantation of Astrocytes Derived From Human Embryonic Stem Cells, in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating transplantation of astrocytes derived from human embryonic stem cells in ALS patients has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Astrocyte transplant derived from human embryonic stem cells

Snippet

Sponsor: Kadimastem | Conditions: ALS (Amyotrophic Lateral Sclerosis) | Phase 1, Phase 2 | Status: COMPLETED